B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Pha 680632

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Pha 680632, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

indirubin
4 shared targets
damnacanthal
2 shared targets
gandotinib
3 shared targets
lx
2 shared targets
reversine
3 shared targets
naphthazalin
2 shared targets
barasertib
4 shared targets
go
3 shared targets
ilorasertib
4 shared targets
bemcentinib
3 shared targets
Loading evidence profile...

This evidence profile for Pha 680632 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.